HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Koji Ohara Selected Research

EGFR-lytic peptide

8/2013Localization of the anti-cancer peptide EGFR-lytic hybrid peptide in human pancreatic cancer BxPC-3 cells by immunocytochemistry.
7/2011Characterization of antilytic peptide antibody: application for the detection of lytic-based hybrid peptide in serum samples.
4/2011A single replacement of histidine to arginine in EGFR-lytic hybrid peptide demonstrates the improved anticancer activity.
3/2011A novel hybrid peptide targeting EGFR-expressing cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Koji Ohara Research Topics

Disease

11Neoplasms (Cancer)
11/2014 - 09/2007
6Pancreatic Neoplasms (Pancreatic Cancer)
08/2013 - 01/2011
3Bullous Pemphigoid (Pemphigoid)
04/2016 - 08/2014
2Infections
12/2013 - 08/2013
2Breast Neoplasms (Breast Cancer)
07/2011 - 04/2011
1COVID-19
03/2022
1Linear IgA Bullous Dermatosis
02/2015
1Autoimmune Diseases (Autoimmune Disease)
08/2014
1Glioma (Gliomas)
12/2013
1Mitochondrial Diseases (Mitochondrial Disease)
08/2013
1Stomach Neoplasms (Stomach Cancer)
01/2011
1Leukemia
09/2007
1Cardiotoxicity
06/2007

Drug/Important Bio-Agent (IBA)

9Peptides (Polypeptides)IBA
11/2014 - 01/2011
4EGFR-lytic peptideIBA
08/2013 - 03/2011
4ErbB Receptors (EGF Receptor)IBA
10/2011 - 03/2011
3Pharmaceutical PreparationsIBA
03/2013 - 09/2007
2Tyrosine Kinase InhibitorsIBA
04/2011 - 03/2011
1Recombinant ProteinsIBA
04/2016
1EpitopesIBA
04/2016
1AutoantibodiesIBA
02/2015
1Collagen Type VIIIBA
02/2015
1Laminin (Merosin)IBA
02/2015
1AutoantigensIBA
02/2015
1Melitten (Melittin)IBA
11/2014
1B-Cell Activating FactorIBA
08/2014
1CytokinesIBA
08/2014
1Fluorescein-5-isothiocyanate (FITC)IBA
12/2013
1Growth Factor ReceptorsIBA
08/2013
1CaspasesIBA
08/2013
1Hematoxylin (Haematoxylon)IBA
03/2013
1Eosine Yellowish-(YS) (Eosin)IBA
03/2013
1Ethanol (Ethyl Alcohol)IBA
03/2013
1Antineoplastic Agents (Antineoplastics)IBA
03/2013
1Interleukin-4 Receptors (Interleukin 4 Receptor)IBA
01/2012
1Neuropilin-1IBA
10/2011
1Semaphorin-3AIBA
10/2011
1Arginine (L-Arginine)FDA Link
04/2011
1Histidine (L-Histidine)FDA Link
04/2011
1Amino AcidsFDA Link
03/2011
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2011
1Phosphotransferases (Kinase)IBA
03/2011
1hybrid Antp-TPR peptideIBA
01/2011
1Daunorubicin (Cerubidine)FDA LinkGeneric
09/2007
1AnthracyclinesIBA
06/2007
1Anti-Bacterial Agents (Antibiotics)IBA
06/2007

Therapy/Procedure

3Therapeutics
01/2012 - 01/2011
1Synchrotrons
03/2022
1Injections
03/2013